292 related articles for article (PubMed ID: 14872180)
1. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
Bergen R; Black S; Shinefield H; Lewis E; Ray P; Hansen J; Walker R; Hessel C; Cordova J; Mendelman PM
Pediatr Infect Dis J; 2004 Feb; 23(2):138-44. PubMed ID: 14872180
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years.
Belshe RB; Nichol KL; Black SB; Shinefield H; Cordova J; Walker R; Hessel C; Cho I; Mendelman PM
Clin Infect Dis; 2004 Oct; 39(7):920-7. PubMed ID: 15472840
[TBL] [Abstract][Full Text] [Related]
5. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
[TBL] [Abstract][Full Text] [Related]
6. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
[TBL] [Abstract][Full Text] [Related]
7. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
Belshe RB; Gruber WC
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.
Tam JS; Capeding MR; Lum LC; Chotpitayasunondh T; Jiang Z; Huang LM; Lee BW; Qian Y; Samakoses R; Lolekha S; Rajamohanan KP; Narayanan SN; Kirubakaran C; Rappaport R; Razmpour A; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2007 Jul; 26(7):619-28. PubMed ID: 17596805
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.
Vesikari T; Fleming DM; Aristegui JF; Vertruyen A; Ashkenazi S; Rappaport R; Skinner J; Saville MK; Gruber WC; Forrest BD;
Pediatrics; 2006 Dec; 118(6):2298-312. PubMed ID: 17142512
[TBL] [Abstract][Full Text] [Related]
11. Cold-adapted, live attenuated influenza vaccine.
Glezen WP
Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
[TBL] [Abstract][Full Text] [Related]
12. Live attenuated influenza vaccine in children.
Ambrose CS; Walker RE; Connor EM
Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
[TBL] [Abstract][Full Text] [Related]
15. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.
Piedra PA; Yan L; Kotloff K; Zangwill K; Bernstein DI; King J; Treanor J; Munoz F; Wolff M; Cho I; Mendelman PM; Cordova J; Belshe RB
Pediatrics; 2002 Oct; 110(4):662-72. PubMed ID: 12359778
[TBL] [Abstract][Full Text] [Related]
16. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
Karron RA; Belshe RB; Wright PF; Thumar B; Burns B; Newman F; Cannon JC; Thompson J; Tsai T; Paschalis M; Wu SL; Mitcho Y; Hackell J; Murphy BR; Tatem JM
Pediatr Infect Dis J; 2003 May; 22(5):394-405. PubMed ID: 12792378
[TBL] [Abstract][Full Text] [Related]
17. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine.
Vesikari T; Karvonen A; Korhonen T; Edelman K; Vainionpää R; Salmi A; Saville MK; Cho I; Razmpour A; Rappaport R; O'Neill R; Georgiu A; Gruber W; Mendelman PM; Forrest B;
Pediatr Infect Dis J; 2006 Jul; 25(7):590-5. PubMed ID: 16804427
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
Block SL; Toback SL; Yi T; Ambrose CS
Clin Ther; 2009 Oct; 31(10):2140-7. PubMed ID: 19922885
[TBL] [Abstract][Full Text] [Related]
20. Safety of the trivalent inactivated influenza vaccine among children: a population-based study.
France EK; Glanz JM; Xu S; Davis RL; Black SB; Shinefield HR; Zangwill KM; Marcy SM; Mullooly JP; Jackson LA; Chen R
Arch Pediatr Adolesc Med; 2004 Nov; 158(11):1031-6. PubMed ID: 15520339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
